David Arnold

Granulomatous disease: Distinguishing primary antibody disease from sarcoidosis

David Arnold, J Wiggins, Charlotte Cunningham‐Rundles et al. · Clinical Immunology · 2008 · 64 citations · Full text

Granulomatous Disease, Autoimmune Disease, Granulocyte +5

First-in-Human Phase 1a Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Noncovalent Bruton Tyrosine Kinase (BTK) Inhibitor SNS-062 in Healthy Subjects

Linda Neuman, Renee Ward, David Arnold et al. · Blood · 2016 · 30 citations

An ‘n-of-1’ placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris

David Arnold, Janet Burton, Brian Shine et al. · British Journal of Dermatology · 2009 · 29 citations

Predictive Factors for Early Postoperative Hypocalcemia After Surgery for Primary Hyperparathyroidism

Shawn Steen, Brandon Rabeler, T. L. Fisher et al. · Baylor University Medical Center Proceedings · 2009 · 25 citations · Full text

Early Postoperative Hypocalcemia, Endocrine Disease, Predictive Factors +13

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma

Donald T. Weed, Serena Zilio, Christie McGee et al. · Cancer Research · 2023 · 21 citations · Full text